Presbia PLC (NASDAQ:LENS) was upgraded by research analysts at Jefferies Group from a “market perform” rating to a “market outperform” rating in a research note issued to investors on Tuesday, StockTargetPrices.com reports.
LENS has been the topic of several other reports. TheStreet lowered shares of Presbia PLC from a “hold” rating to a “sell” rating in a report on Thursday, September 1st. Zacks Investment Research lowered shares of Presbia PLC from a “hold” rating to a “sell” rating in a report on Tuesday, July 19th. Finally, Rodman & Renshaw set a $14.00 price target on shares of Presbia PLC and gave the company a “buy” rating in a report on Thursday, July 21st.
Shares of Presbia PLC (NASDAQ:LENS) opened at 4.50 on Tuesday. The stock has a 50 day moving average price of $4.44 and a 200 day moving average price of $4.54. Presbia PLC has a one year low of $2.94 and a one year high of $6.89. The company’s market capitalization is $60.02 million.
About Presbia PLC
Presbia PLC is an ophthalmic device company. The Company develops and markets an optical lens implant for treating presbyopia, the age-related loss of the ability to focus on near objects. The Company’s segment is the restoration of clear vision caused by presbyopia. The Company provides the refractive lens for patient surgeries and accessories for procedures performed exclusively outside the United States.
Receive News & Ratings for Presbia PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Presbia PLC and related companies with MarketBeat.com's FREE daily email newsletter.